3 Radar Stocks After the Bell: Insmed Up 1% After 31% Plunge, Alcoa Edges Up...
Insmed, Inc. (NASDAQ:INSM) is trading 1% higher in late trading after a 30.8% plunge during regular market hours. Shares took a nasty fall after the US Food and Drug Administration kept in place a halt...
View ArticleGoogle, Capital One, Insmed Attract Major Attention in Trading January 20th
Google Inc (NASDAQ:GOOG): Intel (NASDAQ:INTC) CEO Paul Otellini said last night that tablets running on Microsoft’s (NASDAQ:MSFT) Windows 8 operating system are “being queued up for production,”...
View ArticleInsmed Inc. Earnings Cheat Sheet: Revenue Rises, Beats Analyst Estimate
Insmed Inc. (NASDAQ:INSM) reported its results for the fourth quarter. Insmed is a biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases and...
View ArticleClik here to view.
Early Morning Trading Targets: AIG, Insmed, Cognizant Technology Solutions
Uncle Sam is getting paperwork together to dump $5 billion of shares in American International Group Inc. (NYSE:AIG). The Treasury is selling the shares at $30.50 each, just below AIG’s closing price...
View ArticleVertex, GTSI, Insmed, DISH Most Active Stocks in Monday Morning Trading
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Vertex announced an interim analysis of data from an ongoing Phase 2 study of VX-809 and KALYDECO that showed significant improvements in lung function among...
View ArticleHealthcare Business Recap: Insmed Rockets on Good News, Abbott Labs Settlement
The FDA removes its clinical hold on Insmed’s (NASDAQ:INSM) Arikace drug for lung infections in cystic fibrosis patients, and shares soared in early trading. Don’t Miss: Depakote Settlement: Abbott...
View ArticleInsmed Inc. Earnings: Loss Narrows and Tops Forecasts
Insmed Inc. (NASDAQ:INSM) got closer to even, narrowing its loss while beating Wall Street’s expectations. Insmed is a biopharmaceutical company focused on the development and commercialization of...
View ArticleWill Insmed’s Top Institutional Shareholders SELL After Earnings?
In 2012, Insmed Inc.’s (NASDAQ:INSM) shares are up 5.9 percent. On Tuesday, the company reported its second quarter earnings. It saw a narrower loss to $9.7 million ($0.39 per share), down from last...
View ArticleInteraxion to Expand Data Centers and 4 Stocks Rising to 52-Week Highs
Insmed (NASDAQ:INSM): Ayer Capital reported a 9.99% passive stake in Insmed. Their shares closed at $6.30, up $0.96 or 17.98% on the day. They have traded in a 52-week range of $2.64 to $5.50....
View ArticleVIVUS Announces Suit Dismissal and 4 Healthcare Stocks in Demand
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares saw a huge boost following Simeonidis’ informal physician polling which revealed that 70 to 75 percent of doctors attending the Obesity Society meeting...
View Article
